ÂÜÀòÂÒÂ×

Lien Lybaert has a strong background in pharmaceutical sciences and immunotherapy research. Currently, Lien serves as the Chief Development Officer at myNEO Therapeutics, leading the development of groundbreaking immunotherapies to combat cancer. Prior to this role, Lien held positions at Persomed, Vrije Universiteit Brussel, Xedev, 2 Bridge CVBA, and Universiteit Gent, where they contributed significantly to various research and project management initiatives in the field of oncoimmunology. With a Master's degree in Pharmaceutical Sciences and extensive experience in both academia and industry, Lien brings a wealth of knowledge and expertise to the biopharmaceutical sector.